Microsecond molecular dynamics studies of cholesterol-mediated myelin sheath degeneration in early Alzheimer's

Mayuri Gupta1, Donald F Weaver1,2

  • 1Krembil Research Institute, University Health Network, 60 Leonard Avenue, Toronto, M5T 0S8, Canada. donald.weaver@uhnresearch.ca.

Insights

Altered cholesterol levels in brain white matter membranes disrupt structural integrity, contributing to early Alzheimer's disease (AD) pathogenesis. Molecular simulations reveal how cholesterol impacts myelin sheath properties, increasing neuronal vulnerability.

Area of Science:

  • Neuroscience
  • Biophysics
  • Computational Biology

Background:

  • Cholesterol's role in membrane integrity is crucial for neuronal health.
  • Alzheimer's disease (AD) pathogenesis involves cholesterol-mediated membrane disruptions, proteopathy, and immunopathy.
  • White matter atrophy, linked to cholesterol changes, precedes conventional AD biomarkers.

Purpose of the Study:

  • To investigate the biophysical and mechanical properties of myelin sheath membranes.
  • To understand how cholesterol mole fraction (χCHL) affects membrane structure and dynamics.
  • To elucidate the molecular mechanisms underlying myelin sheath's susceptibility in early AD.

Main Methods:

  • Utilized extensive microsecond all-atom molecular dynamics simulations.
  • Analyzed various bilayer properties including APL, chain order, density profiles, moduli, thickness, tilt angles, H-bonding, and tail interdigitation.
  • Modeled healthy myelin sheath (HMS) membranes with varying cholesterol concentrations.

Main Results:

  • Increased cholesterol mole fraction (χCHL) alters multiple myelin sheath bilayer properties.
  • Cholesterol exhibits a condensing effect, increasing orientational ordering of lipid chains.
  • Higher χCHL leads to interfacial region shrinkage and altered water density profiles.

Conclusions:

  • Impaired cholesterol homeostasis significantly affects myelin sheath biophysical properties.
  • These alterations contribute to myelin sheath's susceptibility in the early stages of Alzheimer's disease.
  • Provides a molecular-level understanding of AD pathogenesis linked to white matter changes.